Valérie C.
- Country
- France
- Department
- Oncology
Research Overview
- Phase III Multicentric Study on Chemotherapy Efficacy in Stage III Colorectal Cancer with Positive ctDNA Post-Surgery Using Irinotecan and Drug Combination
- Evaluation of Pembrolizumab Combined with XELOX and Bevacizumab in Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
- Phase II Evaluation of 5-Fluorouracil, Panitumumab, and Sotorasib in First-Line Treatment of Advanced KRAS G12C Mutated Colorectal Adenocarcinoma
Data & Insights
Has run more than one trial at 101 of 237 partner sites.
Specializations
Colorectal Cancer Management
This investigator specializes in the treatment of colorectal adenocarcinoma, with particular emphasis on both early-stage and advanced disease states.
- Stage III Colorectal Cancer Treatment
- Advanced Unresectable Disease Management
- Post-Surgical Care Strategies
Their research encompasses innovative approaches to treating minimal residual disease following surgical intervention.
Precision Medicine Applications
The investigator focuses on targeted therapeutic approaches, particularly in KRAS G12C mutated colorectal cancer treatment protocols.
- Molecular-Targeted Therapies
- Biomarker-Driven Treatment
- Personalized Treatment Strategies
Their work involves integrating circulating tumor DNA analysis for treatment decision-making.
Treatment Innovation
The investigator explores novel therapeutic combinations including targeted biological agents and conventional chemotherapy approaches.
- Combination Therapy Development
- Alternative Treatment Protocols
- First-line Treatment Optimization
Their expertise extends to developing treatments for patients requiring specialized therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.